SOLIACS: Solian Solution in the Acute Setting

Solian Solution to Treat Schizophrenic Patients During an Acute Episode

During this study the efficacy and safety profile will be evaluated of the use of amisulpride in the form of a solution in schizophrenic patients with an acute episode.

The main purpose of the study is to observe the anti-psychotic effect of amisulpride as a solution during the first days of an acute episode of schizophrenia.

Inclusion Criteria:

• schizophrenic in-patients with an acute episode
• aged between 18 and 65 years
• written informed consent

Exclusion Criteria:

• pregnancy and breast-feeding
• breast cancer, prolactinoma, pheochromocytoma
• hypersensitivity to amisulpride or one of the other excipients
• contra-indications when using amisulpride as per the SmPC